Article
A window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act.
American journal of public health - 1 Mar 2015
Haley Sean J, Kreek Mary Jeanne
Abstract excerpt
Patients with chronic HCV have predictable overlapping comorbidities that reduce access to care. The Affordable Care Act (ACA) presents an opportunity to focus on the benefits of the medical home model for integrated chronic disease management. New, highly effective HCV treatment regimens in combination with the medical home model could reduce disease prevalence. We sought to address challenges posed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
